sorafenib 失效, 肺轉伴有症狀,精神不佳. 目前還能travel, 尋求更新療法, 包闊藥試 - HK, 台灣, US. 謝謝關愛.
詳情
Pathology report (by pathologist from Fudan University affiliated Sun Yat-sen Hospital) 複旦大學附屬中山醫院病理報告
female, primary HCC diagnosed Nov 2011
女, 65 歲, 55 KG (58 KG presurgery). 原發性肝細胞肝癌
1) greyish white liver mass, 7.5x6 cm, adjacent to capsular, with 10+ satelite lesions, ranging 0.2 - 0.8 cm in diameter.
肝腫塊 7.5x6 cm, 緊貼肝被膜,子灶10餘個,大小不等, 周圍肝土黃色, 細膩
2) also seen greyish white mass 5x5x4 cm with membrane, section face grey to brown in color, partially hemorragic. Alongside gastric tissue measuring 4x2x1 cm
另見灰白帶包膜腫物一個, 5x5x4 cm, 切麵灰褐, 部分出血, 旁附少許胃組織, 大小 4x2x1 cm
Diagnosis: right-side hepatocellular carcinoma, grade II - III with 2ndary lesions, sorrounding hepatic tissue G1S0; spleen and stomach interstitial stromal tumor,
診斷: 右邊原發性肝細胞肝癌 II 到 III 級, 伴子灶, 周圍肝G1S0; 胃/脾間質瘤, 細胞豐富, 輕度異型, 核分裂相難見.
Treatment history
治療史
Nov 18, 2011 - surgery. Section VI, VII, VIII and partial diaphram resected, stomach partly removed due to GIST 肝六,七,八區切除,部分縱隔,部分胃切除
Nov 18, 2011 - TACE: EADM (表阿黴素) and Lipiodol (碘油)
Feb 7, 2012 - TACE. Mets to both lungs 雙肺多點轉移. Starting sorafenib, 800mg + 800mg per day
Jun 15, 2012 - TACE. Stopped sorafenib
Aur 9, 2012 - TACE + BAI
Aug 16, 2012 - resuming sorafenib 800 mg + 400 mg per day
Laboratory
AFP 60500
CEA 2.17
CA19-9 9.4
AST 66
AP 84
GGT 174
Bile acid 52.0
bilirubin - slightly elevated, 22.4 total/ 7.4 conjugated
kidney function - normal, creatinine 45, urea 1.6 (low), uric acid 159, eGFR 121